iOS app Android app

Ofatumumab Multiple Sclerosis

Multiple Sclerosis Drug Shows Promise In Phase 2 Study

Reuters | Posted 01.23.2014 | Healthy Living

COPENHAGEN, Oct 10 (Reuters) - Danish biotech firm Genmab on Thursday announced positive results from a phase II study of its sclerosis drug candid...